Pharmanutra S.p.A., a nutraceutical company, engages in the research and development and marketing of food supplements and medical devices in Europe, the Middle East, Far East, North America, South America, and internationally. The company produces and distributes raw materials and active ingredients for the food, pharmaceutical, and dietary supplement industries. It offers Sucrosomial, a delivery system that optimises nutrient transport and absorption for minimising gastrointestinal side effects; and Cetylated Fatty Acids, a formulation for muscle and joint recovery in physiotherapy and sports. The company also sells instrumentation and software for body bioimpedance analysis through agents, distributors, and online sales. Pharmanutra S.p.A. was founded in 2000 and is headquartered in Pisa, Italy.
Frequently asked questions
What sector does PHARMANUTRA S.P.A. (761) operate in?
PHARMANUTRA S.P.A. belongs to the Healthcare sector and operates in the Drug Manufacturers - Specialty & Generic industry.
What is PHARMANUTRA S.P.A. (761) current stock price?
As of the latest data, PHARMANUTRA S.P.A. stock price is €73.30, with a previous close of €73.00. PHARMANUTRA S.P.A. gained €0.30 in the last trading session, representing a 0.41% increase.
What is PHARMANUTRA S.P.A. (761) current market capitalization?
PHARMANUTRA S.P.A. market cap is approximately 701.86 million.
What is PHARMANUTRA S.P.A. (761) Earnings Per Share (EPS)?
The trailing EPS is €2.20.
What is PHARMANUTRA S.P.A. (761) Price-to-Earnings (P/E) ratio?
PHARMANUTRA S.P.A. current P/E ratio is 33.32.
Does PHARMANUTRA S.P.A. (761) pay dividends?
Yes. PHARMANUTRA S.P.A. pays annual dividends with an annualized yield of 1.64% and an estimated annual payout of €1.20 per share.
When is the next ex-dividend date for PHARMANUTRA S.P.A. (761)?
The next ex-dividend date is scheduled for May 04, 2027.
What is PHARMANUTRA S.P.A. (761) beta (volatility) score?
PHARMANUTRA S.P.A. has a beta of 0.162, indicating lower volatility than the overall market.
